Control Bionics Limited (ASX:CBL)
Australia · Delayed Price · Currency is AUD 0.0650
+0.0010 (1.56%)
Oct 7, 2026, 2:51 PM AEST
Control Bionics Market Cap
Control Bionics has a market cap or net worth of 35.3 million as of October 7, 2026. That makes Control Bionics the world's 35,669th most valuable company and 915th in Australia. Its market cap has increased by 218.05% in one year.
Market Cap
35.30M
Enterprise Value
33.76M
Revenue
4.77M
Global Rank
Country Rank
#915 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since December 7, 2020, Control Bionics's market cap has decreased from 98.33M to 35.30M, a decrease of -64.10%. That is a compound annual growth rate of -16.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 35.30M | 43.41% |
| Dec 31, 2025 | 24.61M | 62.80% |
| Dec 31, 2024 | 15.12M | 126.88% |
| Dec 29, 2023 | 6.66M | -55.36% |
| Dec 30, 2022 | 14.93M | -59.58% |
| Dec 30, 2021 | 36.94M | -52.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SomnoMed | 63.73M |
| Epiminder | 56.33M |
| Cyclopharm | 55.32M |
| Compumedics | 51.94M |
| HeraMED | 48.66M |
| Cleo Diagnostics | 47.30M |
| Micro-X | 46.65M |
| CleanSpace Holdings | 38.89M |